PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.\', \'BioMediTech Institute, Tampere University, Tampere, Finland.\', \'Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.\', \'Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.\', \'Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.\', \'Synthetic and Systems Biology Unit, Biological Research Centre, Eotvos Lorand Research Network, Szeged, Hungary.\', \'Institute of Biotechnology, University of Helsinki, Helsinki, Finland.\', \'Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.\', \'Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.\', \'Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.\', \'Department of Forensic Psychiatry, Aarhus University, Aarhus, Denmark.\', \'Queensland Brain Institute, The University of Queensland, Brisbane, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • bbab50710.1093/bib/bbab507
?:hasPublicationType
?:journal
  • Briefings in bioinformatics
is ?:pmid of
?:pmid
?:pmid
  • 34962256
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.505
?:rankingScore_hIndex
  • 83
is ?:relation_isRelatedTo_publication of
?:title
  • Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all